dactinomycin has been researched along with Cardiomyopathies in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (57.14) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Prescott, A; Quinlan, RA; Russell, P; van den IJssel, P; Wheelock, R | 1 |
Chan, KW; Fryer, C; Kakadekar, AP; Popov, R; Pritchard, S; Rogers, PC; Sandor, GG | 1 |
Novikova, NA | 1 |
Watts, RG | 1 |
Dong, E; Griepp, RB; Morrell, RM; Phillips, RC; Shumway, NE; Stinson, EB | 1 |
Bieber, CP; Dong, E; Popp, RL; Shumway, NE; Stinson, EB | 1 |
Fishman, AP; Garrett, JC; Morkin, E | 1 |
7 other study(ies) available for dactinomycin and Cardiomyopathies
Article | Year |
---|---|
Nuclear speckle localisation of the small heat shock protein alpha B-crystallin and its inhibition by the R120G cardiomyopathy-linked mutation.
Topics: alpha-Crystallin B Chain; Antibiotics, Antineoplastic; Biomarkers, Tumor; Cardiomyopathies; Cell Line; Cell Nucleolus; Cell Nucleus; Dactinomycin; Heat-Shock Proteins; HeLa Cells; HSP27 Heat-Shock Proteins; Humans; Inclusion Bodies; Molecular Chaperones; Mutation; Neoplasm Proteins; Nuclear Proteins; Protein Isoforms | 2003 |
Differences in dose scheduling as a factor in the etiology of anthracycline-induced cardiotoxicity in Ewing sarcoma patients.
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Echocardiography; Female; Heart; Humans; Male; Retrospective Studies; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms | 1997 |
[Glucose-6-phosphate dehydrogenase of neurogenically damaged heart].
Topics: Animals; Cardiomyopathies; Dactinomycin; Glucosephosphate Dehydrogenase; Heart; Male; Myocardium; Norepinephrine; Rats | 1978 |
Severe and fatal anthracycline cardiotoxicity at cumulative doses below 400 mg/m2: evidence for enhanced toxicity with multiagent chemotherapy.
Topics: Adult; Antibiotics, Antineoplastic; Bleomycin; Cardiomyopathies; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Heart; Humans; Male; Methotrexate; Sarcoma | 1991 |
Use of antithymocyte globulin in human heart transplantation.
Topics: Animals; Antilymphocyte Serum; Arteriosclerosis; Cardiomyopathies; Dactinomycin; Graft Rejection; Heart Transplantation; Histocompatibility Testing; Horses; Humans; Immunosuppression Therapy; Lymphocytes; Male; Methylprednisolone; Middle Aged; Myocardial Infarction; Prednisone; Thymus Gland; Transplantation Immunology; Transplantation, Homologous | 1972 |
Cardiac transplantation in man. II. Immunosuppressive therapy.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cardiomyopathies; Coronary Disease; Dactinomycin; Female; Heart Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Long-Term Care; Male; Methylprednisolone; Middle Aged; Transplantation Immunology; Transplantation, Homologous | 1969 |
Effects of actinomycin D and hypophysectomy on development of myocardial hypertrophy in the rat.
Topics: Animals; Aorta, Abdominal; Blood Pressure; Body Weight; Cardiomyopathies; Carotid Arteries; Dactinomycin; Female; Heart; Heart Rate; Heart Ventricles; Hypertrophy; Hypophysectomy; Organ Size; Rats | 1968 |